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Background:
Screening asylum-seekers for active pulmonary tuberculosis is
common practice among many European countries with low
incidence of tuberculosis. The reported yields vary substan-
tially, partly due to the heterogeneous and dynamic nature of
asylum-seeking populations. Some countries apply targeted
screening measures based on the incidence of tuberculosis in
the country of origin. Evaluations of such approaches with
respect to (cost)-effectiveness is scarce.
Methods:
Using screening data from a large German state over 14 years
(2002-2015), we evaluate the cost-effectiveness of targeted
screening based on WHO-reported incidence of tuberculosis in
country of origins (from thresholds of 50 to 250/100,000
inhabitants). Incremental cost-effectiveness is measured as cost
per case found and cost per case prevented.
Results:
Incremental cost-effectiveness ratios (ICERs) of screening
asylum-seekers from countries with an incidence of 50 to
250/100,000 range between 15,000E and 17,000E per addi-
tional case found when compared to lower thresholds. The
ICER for additional screening of asylum-seekers from
countries with an incidence <50/100,000 is 112,000E per
additional case found. Costs per case prevented show a similar
increase in costs.
Conclusions:
The high cost per case found or case prevented in the <50/
100,000 threshold scenario suggests this threshold to be a
sensible cut-off for targeted screening. Acknowledging that no
screening measure can find all cases of tuberculosis, and that
reactivation of latent infections makes up a large proportion of
foreign-born cases, targeting asylum-seekers from countries
with an incidence above 50/100,000 is likely to be a more
reasonable screening measure for the prevention and control of
tuberculosis than indiscriminate screening measures.
Key messages:
 We challenge the widespread belief that indiscriminate
tuberculosis screening programmes are placed at an
acceptable balance between costs and benefits.
 Targeting asylum-seekers from countries with an incidence
above 50/100,000 is likely to be a reasonable screening
measure for the prevention and control of tuberculosis.
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Background:
The Aberdeen Children of the 1950s (ACONF) cohort
comprises 12,150 people born in Scotland in the 50s. It
contains rich early life data, questionnaire data from mid-life
and linked electronic health records. Involving participants in
designing future data collection is key to ensure research is
acceptable and reflects public priorities.
Aim:
Gather ACONF members views to inform how to: research
healthy ageing, optimise recruitment and maximise participation.
Methods:
3 co-design workshops with 30 ACONF members. A discus-
sion was led by a facilitator using guidance questions
developed by the study team. Workshops were recorded and
transcribed.
Results:
Participants viewed healthy ageing as keeping socially and
physically active, taking responsibility for oneself and having a
positive attitude to ageing. Research priorities were dementia,
improvements in the social care system and engaging hard-to-
reach groups. Members were keen for future research
involvement. Recruitment may be maximised by: more
information online, involving participants in recruiting other
study members and clarity about potential benefits to
themselves or others. It was acceptable to ask their offspring
to participate. There were high levels of trust in researchers,
but ongoing data protection is vital. Participation may be
improved by regular contact (informing members of results,
engagement events, phone ‘‘apps’’). Participants viewed
various data collection methods (questionnaires, applications,
wearable devices, in-person tests, DNA collection and electro-
nic record linkage) as acceptable.
Conclusions:
Participant involvement is a fundamental part of securing a
social license for research. Participants were in favour of
ongoing research, including recruitment of their children. The
workshops highlighted key considerations for future research
and data collection.
Key messages:
 Co-design is vital for highlighting research topics which are
important and relevant to the general population.
 Co-design can highlight strategies for maximising research
participation and securing a social license for research.
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2Departamento de Ciências da Saúde Pública e Forenses e Educa, Faculdade
de Medicina, Universidade do Porto, Porto, Portugal
3CIES-IUL, Instituto Universitário de Lisboa, Lisbon, Portugal
4Centro de Referencia Doenças Hereditárias do Metabolismo, Centro
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Background:
Public involvement in the governance of epidemiological and
public health studies can foster needs-driven research, enhance
participants’ recruitment, reduce attrition and improve the
quality of and ethics in research and surveillance. However, it
can also reinforce health inequalities if it fails to ensure public
representation across socioeconomic gradients. This study
aimed to assess patients’ and carers’ preferences for involve-
ment in collective health data governance, and its associated
factors, to strengthen the evidence base for policy
development.
Methods:
Between June 2019 and January 2020, 644 people (157 patients
and 487 carers; participation rate=89.3%) followed at two
reference centres for rare diseases in a university hospital from
Northern Portugal were enrolled in an observational cross-
sectional study. Data about willingness to participate in data
governance was collected through four intersecting options:
periodic or sporadic meetings, by either giving opinions
(consultation) or participating in decision-making
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(deliberation). Data were analysed using descriptive and
inferential statistics.
Results:
From a total of 629 respondents, 39% are willing to get
involved through at least one of the four participatory options
and 16% do not want to participate. Patients and carers do not
differ in their preferences for involvement. Sex and education
are associated with willingness to participate, after adjustment
for participant type (patient/carer), occupation and trust in
national and international institutions (OR:1.60; 95%CI 1.05-
2.45 for men vs. women and OR:1.65; 95%CI 1.07-2.56 for >12
vs. 12 educational years). Participants’ preferred option for
participation is consultative sporadic meetings (29.5%).
Conclusions:
Anticipating which social groups are likely to become under-
represented in participatory exercises is crucial to inform
policy aimed at promoting inclusive involvement in health
data governance.
Key messages:
 Men and higher educated participants are more willing to
participate.
 Forecasting potential for subgroup under-representation is
crucial to develop policy for inclusive participatory data
governance.
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The global collaborations and partnerships in research and
science are evidently growing as an inevitable reality to tackle
the mounting common global challenges. To overcome all of
these challenges and create a balance between countries,
institutions, stakeholders, and fields and to strengthen the
research and science fair collaborations and boost institutional
research capacities and potential, the Council on Health
Research for Development (COHRED), developed an evi-
dence-based tool, the Research Fairness Initiative (RFI). This
paper investigates the RFI experience and application among
the Middle East partners to propose better ways for better
research and science collaborations. The COHRED team used
two scientific methods to understand the region’s stakeholders
on research collaboration. 7 telecom. meetings were carried
out with 7 academic institutions in the region and a literature
review was implemented. Partners in the region were largely
interested when the RFI was introduced to 7 academic
institutions from five countries: Palestine, Egypt, Lebanon,
Jordan, and Saudi Arabia. 3 have launched the work of the RFI
and they will be potential RFI reporting institutions by
submitting RFI report. Efforts seeking to build and strengthen
research and scientific collaborations receive real attention and
also evidently proves the lack of collaboration and partnership
platforms and frameworks is a reality. The RFI was seen as a
useful institutional instrument to develop the institution’s
capacity. The major reason behind this is that the institutions
are lacking structural, technical, logistical, ethical, resource
capacities to establish and develop regional and international
research and scientific collaborations. Research collaboration is
a global, regional, and national priority and RFI is evidently
recognized as a realistic and forward-thinking tool in building
collaborations based on fairness, integrity, impact, and
transparency.
Key messages:
 RFI is one of the best institutional reporting tools that
ensure equitable and fair research collaborations.
 Research collaboration is a global, regional, and national
priority for the slow-developing countries (Middle East
region).
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Background:
Political, economic and climate events continue to bring the
dismantling of communities and creation of new ones.
Understanding successful models of adaptation and working
with communities to address their health and wellbeing needs
requires ethically sound public health research. Community-
Based Participatory Research (CBPR) has been proposed as an
equitable, empowering partnership approach to collaborative
health research that encapsulates analysis, advocacy and action
for the future wellbeing of communities. Meanwhile, a strong
interest in ethical implications of CBPR continues in
international literature, yet with a notable lack of research
that captures the experience of researchers who had ethical
challenges in their CBPR studies. The aim of this research was
to address this lack of evidence by exploring those experiences
of CBPR researchers internationally.
Methods:
An innovative data collection method was designed utilising a
purpose-built blog. This internet-based, qualitative online
study enabled asynchronous international data collection on
the blog. Participants were researchers with experience of
CBPR and were recruited through social media platforms. Blog
narratives of first-hand experiences of CBPR researchers were
analysed using thematic analysis.
Results:
The themes that emerged from blog data analysis were
researchers’ challenges with balancing participant protection
and autonomy, dealing with partnership tensions, and the
enduring impacts on the researchers.
Conclusions:
This study enhances our understanding of ethical challenges in
CBPR with evidence of enduring impacts on researchers of the
’tightrope’ they walked in the interests of maintaining research
integrity and ethical responsibility towards their partnering
communities. Challenges arose largely from complexities of
CBPR coupled with rigid regulatory structures of human
research ethics review that struggles to respond adequately in
the interests of communities and researchers.
Key messages:
 At this critical time for the future of humanity, communities
can benefit from CBPR.
 A positive way forward for ethical review of CBPR exists for
those with power to make a difference.
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Background:
Dwindling governmental funding for widespread natural
disasters and armed conflicts have attracted corporate funding
for humanitarian assistance. Although such funding has
allowed expansion of humanitarian programs and capacity
building, evaluations of such partnerships are rare and focus
only on management aspects, without attention to possible
influences on the organizations themselves and the popula-
tions they serve. Given the well-established conflicts of interest
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